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Background and purpose:Delirium is associated with increased mortality, length of stay 
and poor functional outcome following critical illness.  The epidemiology of delirium in 
stroke is poorly described.  We sought to collate evidence around occurrence (incidence 
and/or prevalence) of delirium in acute stroke. 
Methods:We searched multiple, cross-disciplinary electronic databases using a pre-
specified search strategy; complemented by hand searching.  Eligible studies described 
delirium in acute (first six weeks) stroke.  We compared delirium occurrence using random 
effects models to describe summary estimates.  We assessed risk of bias using the 
Newcastle-Ottawa tool, incorporating this in sensitivity analyses.  We performed subgroup 
analyses for:delirium diagnostic method (confusion assessment method scoring [CAM]; 
clinical diagnosis; other); duration and timing of delirium assessment (greater or less than 
one week) and performed meta-regression based on year of publication. 
Results:Of 8,822 titles, we included 32 papers (6,718 participants) in the quantitative 
analysis.  Summary estimate for occurrence of delirium was 25% (95%CI:20%-30%, 
moderate quality evidence).  Limiting to studies at low risk of bias (22 studies, 4,422 
participants) the occurrence rate was 23% (95%CI:17%-28%).  Subgroup summary estimates 
suggest that delirium occurrence may vary with assessment method:CAM:21% (95%CI:16%-
27%); clinical diagnosis:27% (95%CI:19%-38%); other:32% (95%CI:22%-43%) but not with 
duration and timing of assessment.  Meta-regression suggested decline in occurrence of 
delirium comparing historical to more recent studies (slope-0.03(SE:0.004) p<0.0001). 
Conclusions:Delirium is common, affecting one in four acute stroke patients. Reported 
rates of delirium may be dependent on assessment method. Our estimate of delirium 
occurrence could be used for audit, to plan intervention studies and inform clinical 
practice.  
PROSPERO registration number:CRD42015029251  
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Introduction 
Delirium is a serious neuropsychiatric complication of critical illness.  Delirium adversely 
affects mortality and functional outcomes in many healthcare settings.1  There are limited 
published data on delirium in stroke but available evidence suggests a similar pattern of 
higher mortality and poorer outcome.2  Evidence based intervention for delirium is 
described3, and recent guidance emphasises the importance of routinely observing and 
testing for delirium in high risk groups such as unscheduled older adult hospital 
admissions.4  International stroke guidelines do not explicitly mention delirium, but 
screening for delirium in acute stroke settings is increasingly performed.5 
Estimates from studies describing delirium rates following stroke have varied 
considerably.6,7  Methodological factors may have influenced the delirium rates described.8  
Some studies have tested for delirium over a defined time period9 while others have only 
described point prevalence.10  Equally the assessment methods used to detect delirium11 
have varied across studies.12-14  It is also possible that delirium rates may have changed 
over time.  Delirium is said to be a marker of quality of care15 and in the context of 
improving stroke care in the last decade, temporal change in rates of delirium seem 
plausible.  Active screening for delirium may have led to increased detection rate or 
better care processes may have led to reduced rates.  Any attempt to review delirium 
epidemiology needs to address these points. 
A contemporary synthesis of the available literature that offers robust estimates of rates 
of delirium in stroke could be useful for clinical practice, policy and research.  The aim of 
this review was to collate the available evidence to allow a description of the occurrence 
(the combination of incident (develops after admission) and prevalent (present on 
admission)) delirium in patients hospitalised with acute stroke.  Our secondary aims were 
to look at the effect of method of delirium assessment, timing and duration of assessment 
and temporal change. 
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Methods 
The data that support these systematic review findings are presented in the main 
manuscript and supplementary materials, any other study level data not included in these 
materials are available from the corresponding author upon reasonable request. 
 
We followed Preferred Reporting in Systematic Review and Meta-Analysis (PRISMA) 
guidance for the conduct and reporting of this review.  We created a protocol, available 
through the PROSPERO registry (registration number:CRD4201502951,submitted 
13/11/2015,http://www.crd.york.ac.uk/PROSPERO/) 
Each aspect of the review was performed by at least two reviewers trained in systematic 
review methodology (RS,GW,EE) with access to a third arbitrator (TQ) as required. 
Search strategy:Electronic database searching used a sensitive search strategy, employing 
validated search filters for concepts of ‘stroke’ and ‘delirium’ (Supplementary Methods I) 
combined with the Boolean operator “and”.  We searched multiple, cross-disciplinary 
electronic databases:MEDLINE (OVID),EMBASE (OVID),PsycINFO (EBSCO),psycARTICLES 
(EBSCO),CINAHL (EBSCO),Alois (Cochrane), from inception to June 2018. 
References from reviews and other relevant studies were assessed for additional titles.  
We hand searched relevant high impact journals:Stroke (American Heart Association); 
International Journal of Stroke, (World Stroke Organisation) and Age and Aging (British 
Geriatrics Society) for relevant articles published between January 2010 and June 2018.  
Process continued until no new titles were found.  
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If relevant abstracts were discovered but the paper was not available the author was 
contacted regarding publication status.  Where relevant data were not available in the 
published manuscript we also contacted authors.  We translated foreign language papers. 
 
Population:“Acute” stroke was defined as the period from ictus to six weeks post event. 
The definition of stroke was based on World Health Organisation definition.16 We included 
studies where TIA or minor stroke were admitted. Where studies included a mixed 
population of stroke and subarachnoid haemorrhage or traumatic brain injury, we 
excluded those studies where these groups comprised more than 15% of the total 
population, as their psychological sequela may differ from other stroke syndromes. 
 
Inclusion/exclusion:We screened titles and abstracts for relevance on the basis of the 
following inclusion and exclusion criteria.  Studies describing human stroke survivors in any 
languages were considered.  Cross-sectional, prospective and other cohort study designs 
were eligible.  We excluded case studies with too few patients to gain reliable conclusions 
(<20 patients with stroke) and studies of delirium tremens.  Case-control studies and 
randomised control trials were excluded as they would not give representative population 
data.  Although we searched ‘grey literature’, we restricted inclusion to studies published 
in peer reviewed journals.  
 
Data extraction:We extracted data from eligible papers to a pre-specified and piloted 
proforma, based on the Cochrane data extraction tool.17  We extracted an estimate of 
delirium rate, corresponding variance and details relevant to subgroup analyses.  We 
recorded inclusion/exclusion criteria of the studies and whether patients were excluded 
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on the basis of stroke impairments or pre-existing psychiatric diagnosis, including 
dementia.  
We assessed internal and external validity using the Newcastle Ottawa assessment for 
cross-sectional studies.18  The tool was modified for this study by making the “exposure” 
stroke and the “outcome” delirium.  The modified tool was piloted on two papers and 
refined as necessary.(Supplementary Methods II)  We assessed each domain and made a 
judgement on risk of bias at study level.  
We made an assessment of overall strength of evidence based on the Grading of 
Recommendations, Assessment, Development and Evaluation (GRADE) framework, 
modified to be suitable for an observational epidemiology question.19  We assessed risk of 
bias; consistency of results (heterogeneity); directness (applicability of included studies to 
research question); precision (based on confidence intervals of summary estimate) and 
publication bias (funnel plot). 
 
Analyses:As a validation of our search strategy, we compared included studies from our 
initial search to a list of three preselected papers relevant to the topic, to ensure these 
papers were returned and selected.8,20,21 
We created a forest plot of all estimates and 95% confidence intervals.  Given the likely 
heterogeneity in the included datasets, we favoured random effects models for summary 
estimates of delirium occurrence.  We assessed for heterogeneity using a visual 
assessment of forest plots and a quantitative assessment (Higgin’s I2).  
We conducted sensitivity analyses based on quality assessment, limiting analysis to those 
studies judged to be at low risk of bias in all areas or where only one area was uncertain.  
We performed subgroup analyses based on method of assessment, period and duration of 
assessment.  For assessment method we categorised as ‘clinical diagnosis’ (using 
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recognised clinical classification such as Diagnostic and Statistics Manual [DSM])22, 
‘Confusion Assessment Method [CAM]’14 (the most widely used delirium assessment tool) 
and ‘other’.  We categorised period of assessment as timing of assessment in relation to 
stroke (patients tested at <1 week or >1week); duration of assessment compared single 
assessment to multiple assessments.  To assess for temporal change in delirium occurrence, 
we inspected the forest plot re-arranged in chronological order performed meta-regression 
of log delirium rate against year of study.  We assessed publication bias using a funnel plot.  
All quantitative analyses were performed using Comprehensive Meta-Analysis (version 
2.2,USA). 
 
Results 
With duplicates removed we assessed 8,822 titles.  Of 132 full text papers assessed, 
326,7,9,10,12-14,21-46 were included in quantitative analysis (6718 patients). The review 
included cohorts from 19 different countries.  Only one eligible article was not published 
in English (Russian)29 and study author assisted with data extraction in English.  Six 
relevant abstracts were not included as authors reported that full papers had not been 
written and there were no immediate plans to do this.(Figure 1)  Our search strategy was 
proven valid as our three pre-selected papers were returned on initial search.  
Across 32 included studies, there was variation in the included patients (Tables 1-2, 
Supplementary Table I) and variation in delirium occurrence:range 6.7%6 to 61%.32(Figure 
2a,b)  There was substantial statistical heterogeneity in the results, I2 value:93.6%.  The 
summary value of delirium occurrence was 25% (95%CI:20%-30%).  (For comparison, the 
fixed effects estimate was 24% (95%CI:23%-25%).  
We judged 22 studies (n=4422 participants) to have low risk of bias.  The main reason for 
scoring high or uncertain risk of bias was around selection of the population (13/32 papers 
[41%]), with studies excluding those patients likely to be at highest risk of delirium, for 
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example pre-existing dementia or severe stroke.(Table 3)  On sensitivity analysis limited 
to studies considered low risk of bias, summary value for delirium occurrence was 23% 
(95%CI:18%-28%).(Supplementary Figure I)   
There were 26 different tests used in the assessment of delirium or cognition across the 32 
papers. On subgroup analysis by method assessment, validated clinical diagnosis [DSM] 
(n=11 studies; n=1827participants) gave a summary estimate of 27% (95%CI:19%-38%); CAM 
(n=15 studies; n=3702participants) gave a summary estimate of 21% (95%CI:16%-27%), 
other diagnosis (n=6 studies; n=634participants) gave a summary value of 32% (95%CI:22%-
43%).(Supplementary Figure II)   
On subgroup analysis describing period of assessment, testing for <1 week (n=15 studies; 
n=2592 participants) gave a summary delirium occurrence of 24% (95%CI:18%-31%) while 
testing for>1 week (n=16 studies; n=3887 participants) gave a summary estimate of 24% 
(95%CI:18%-31%).(Supplementary Figure III)  On exploratory subgroup analysis of studies 
only assessing participants at one time-point (n=16 studies; n=2594participants) summary 
value for delirium was 24%(95%CI:19%-31%) while studies conducting repeat (>1) 
assessments (n=15 studies; n=3052participants) had a summary value of 26%(95%CI:20%-
33%).(Supplementary Figure IV)   
Meta-regression showed an inverse relationship between year of study and delirium 
occurrence (slope-0.03(SE:0.004) p<0.0001).(Figure 3)  The more recent studies reported 
lower delirium occurrence, for example 1987 delirium occurrence:0.61 (95%CI:0.45-0.75, 1 
paper); 2017 delirium occurrence:0.16 (95%CI:0.13-0.18, 4 papers).  
Our funnel plot analysis suggested no substantial publication bias.(Supplementary Figure V)  
The overall assessment of quality of evidence was graded as moderate.  We deducted 
points for inconsistency in individual study estimates and due to uncertain risk of bias we 
chose the moderate descriptor.(Figure 1)  
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Discussion 
Our systematic review suggests high rates of delirium in stroke; with around one in four 
having delirium in the acute period.  Although there were issues with heterogeneity and 
risk of bias, our estimates remained reasonably robust in a series of sensitivity and 
subgroup analyses.  
To put our results in context, a previous review of delirium post stroke, published in 2010, 
gave a similar estimate of incident events (26%, range:2-66%).8 However, the majority of 
papers included in our review (23 papers [72%]) were published since 2010, demonstrating 
the growing interest in this area.  The between study heterogeneity will in part relate to 
case-mix and we note differing ages and comorbidities of included populations.  Recent 
estimates of delirium in medical inpatients, excluding stroke, suggest occurrence of 20% 
reaching greater than 40% in older adults.47  In a review of delirium in critical care 
delirium occurrence ranged from 45-87%.48   Stroke is an emergency condition typically 
seen in older adults and so, one may have expected delirium occurrence to be closer to 
the 40% reported in these populations.   
Various approaches were used to assess for delirium.  If we consider clinical diagnosis 
using DSM or similar as ‘gold standard’, our results suggest that assessment with the CAM 
screening tool may under-estimate delirium, while use of bespoke and non-validated tools 
may over estimate, albeit there was some uncertainty and confidence intervals 
overlapped.  Various assessments of cognition were used, many of which are not 
recommended in delirium assessment guidance.5  It is notable that the ‘outliers’ in our 
analyses, on the whole, used non-validated approaches to delirium assessment.  
Our subgroup analysis describing period of assessment suggested no difference when 
comparing longer and shorter assessment.  Intuitively, assessing over a longer period 
should give higher occurrence as there is a longer time for incident delirium secondary to 
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complications of stroke.  Our data are consistent with previous studies where majority 
delirium was detected on the first day of admission and the remainder appeared within 
the next 5 days.14  This ‘front loading’ of delirium could be due to the patient conditions 
tending to be worse on admission and then improving with specialist stroke unit care.  The 
same pattern is seen with delirium in acute medical admissions49 and highlights that 
screening and preventive interventions need delivered as soon as possible.   
Our meta-regression confirms a temporal trend towards decreasing delirium incidence 
over time.  There are many potential reasons for this encouraging result and the 
explanation is likely to be multifactorial.  One plausible reason is that the specialist 
multidisciplinary care offered in stroke units is similar to the multicomponent 
interventions proven to reduce delirium incidence in older adult inpatients.15  This may 
also explain why our rates of delirium occurrence, while high, are lower than seen in other 
critical care settings. 
Through our comprehensive search strategy, stringent inclusion/exclusion criteria, 
assessment of risk of bias and pre-specified subgroup analyses we feel we offer a valid 
summary of the published literature on delirium in stroke.  There are caveats to the 
interpretation and application of GRADE and funnel plots in observational epidemiology 
and as with any systematic review, conclusions are limited by the validity of the studies 
available in the published literature. 
There are reasons to suspect that the ‘real world’ occurrence of delirium may be higher 
than our estimates.  This is reflected in our GRADE assessment of moderate quality.  We 
note that many of the studies in our review excluded patients with pre-stroke dementia, a 
factor which is common and associated with incident delirium.  Other studies excluded 
patients with aphasia, severe illness or those unable to be tested, all of which are likely to 
systematically under-estimate delirium.  We recognise the difficulty in performing 
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neuropsychological assessment in those with such impairments, but assessment for 
delirium is possible with sufficient time and training. 
We have described a high occurrence of delirium in acute stroke.  Our data can be used 
for audit, to plan intervention studies and inform clinical practice.  The relatively high 
rates of delirium should be a call to action, as delirium is a serious20 yet potentially 
preventable condition.3  The frequency of delirium is similar to frequency of other stroke 
complications such as aspiration pneumonia and venous thromboembolism.  Evidence 
based assessment and preventive interventions have reduced morbidity and mortality from 
these complications, yet at present delirium is not prioritised in stroke guidelines.  Staff in 
the hyper-acute units should be especially vigilant as delirium seems to be most common 
in the first few days post ictus.  
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Figure Legends 
 
Figure 1. PRISMA flow diagram 
 
Figure 2a,b. Occurrence of delirium in acute stroke, a) forest plot b)GRADE 
assessment  
 
Figure 3. Meta-regression of delirium against year of study  
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Table 1. Characteristics of included studies  
Author and 
Year 
Country 
Sample 
(n) 
Setting Type of Stroke 
Delirium 
Assessment* 
Excluded stroke 
impairments 
Excluded 
psychiatric 
syndromes 
1 Alvarez-Perez 
201840 
Portugal 1072 Stroke All stroke 
Case note 
review DSM 
No No 
2 Caeiro 2004
23 Portugal 218 ASU 
All stroke 
(SAH 12.84%) 
DSM Not reported Not reported 
3 Dahl 2010
24 
Norway 
 
178 SU All stroke CAM Not reported Not reported 
4 Dostović 
200838 
Bosnia and 
Herzegovia 
233 SU All stroke DSM Yes, aphasia Yes, dementia 
5 Fassbender 
199425 
Germany 23 Hyperacute SU Ischaemic stroke DSM No Yes 
6 Gustafson 
19917 
Sweden 
 
145 SU All stroke, TIA DSM 
Yes, decreased 
GCS, aphasia 
Not reported 
7 Gustafson 
199313 
Sweden 83 SU 
Supratentorial 
cerebral infarction 
DSM 
Yes, decreased 
GCS 
Yes 
8 Henon 1999
26 France 202 SU 
All stoke 
 
DSM No Yes 
9  Hosoya 2018
41 Japan 239 
Stroke care 
centre 
All stroke* Other (ICSDC) Not reported Not reported 
10 Infante 2017
42 Italy 100 
Tertiary stroke 
care centre 
Acute stroke DSM, 4AT Yes, aphasia Yes 
11 Kara 2013
27 Turkey 150 
Neurology 
department 
Unspecified DSM Yes, aphasia, Not reported 
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12Kostalova 
201228 
Czech 
Republic 
100 SU All stoke Clinical Not reported Yes 
13 Kowalska 
201843 
Poland 144 
Neurology 
department 
Ischaemic stroke CAM Yes, aphasia Not reported 
14 Kozak 2017
12 Turkey 60 SU All stroke DSM, DRS Yes, aphasia Yes 
15 Kutlubaev 
201329 
Russia 96 SU Unspecified DSM Not reported Yes 
16 Lees 2013
9 Scotland 101 SU All stroke CAM No No 
17 Lees 2017
30 Scotland 51 SU All stroke CAM No No 
18 Lim 2017
6 Korea 576 SU All stroke CAM Not reported Not reported 
19 McManus 
201131 
England 82 SU All stroke CAM Not reported Not reported 
20 Mitasova 
201214 
Czech 
Republic 
129 SU All stroke CAM Not reported Yes 
21 Miu 2013
32 Japan 314 SU All stroke 
CAM 
 
Not reported Yes 
22 Mori 1987
33 Japan 41 
Neurology 
Service 
RMCA stroke Clinical 
Yes, prior stroke, 
aphasia 
Yes 
23 Naidech 
201310 
USA 114 SU ICH CAM Not reported Not reported 
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* If subarachnoid haemorrhage (SAH) was included in the population, numbers are described  
† two group study; the control group of normal care was used in the review 
SU=stroke unit; ICH=intracerebral haemorrhage; CAM=confusion assessment method; ICSDC=Intensive care delirium screening checklist; 
DSM=Diagnostic and Statistics Manual; DOS=Delirium Observation Screening Scale 
24 Nydahl 2017
39 Germany 309 SU 
All stroke 
 
CAM Not reported Not reported 
25 Ojagbemi 
201734 
Nigeria 
 
101 ASU All stroke CAM, DSM Yes, aphasia No 
26 Oldenbeuving 
201121 
Netherlands 527 SU All stroke CAM Not reported Not reported 
27 Pasinska 
201844 
Poland 750 SU All stroke CAM Not reported Not reported 
28 Reding 1993
35 USA 44 
Rehabilitation 
unit 
Unspecified Clinical No No 
29 Rosenthal 
201845 
USA 150 Neuro-ICU ICH CAM Not reported Not reported 
30  Sheng 2006
36 Australia 156 SU All stroke Clinical Not reported Yes 
31 Song 2018
46† Korea 54 SU Unspecified Other (DOS) Yes, aphasia Yes 
32 Turco 2013
37 Italy 176 
Rehabilitation 
unit 
Unspecified CAM No No 
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Table 2. Patient characteristics of included studies 
Author Year 
Sample 
Size 
Mean Age 
Females  
N (%) 
Delirium 
cases (n) 
Percentage 
delirium (%) 
1 Alvarez-Perez 
201840 
1072 
68.0(median) 
range:77.0-83.0 
507 (47.3%) 118 10.2 
2 Caeiro 2004
23 218 57.0±13.0 88 (40.4%) 29 13.0 
3 Dahl 2010
24 178 73.0 76 (42.7%) 18 10.0 
4 Dostović 2008
38 233 Not recorded Not recorded 59 25.3 
5 Fassbender 1994
25 23 
72.0(median) 
range:39.0-89.0 
12 (52.2%) 9 39.0 
6 Gustafson 1991
7 145 
73.0 
range:40.0-101.0 
55 (37.9%) 69 48.0 
7 Gustafson 1993
13 83 74.7±8.1 31 (37.3%) 35 42.0 
8 Henon 1999
26 202 
75.0(median) 
range:45.0-101.0 
105 (52.0%) 49 24.3 
9  Hosoya 2018
41 239 75.0±1.3 
Not available 
for subgroup 
80 33.5 
10 Infante 2017
42 100 
79.0(Median) 
range:19.0-93.0 
Not recorded 50 50.0 
11 Kara 2013
27 150 68.0±1.9 45 (30.0%) 42 28.0 
12Kostalova 2012
28 100 73.5±11.5 47 (47.0%) 43 43.0 
13 Kowalska 2018
43
 144 
69.0(median) 
range:63.0-79.0 
61 (42.4%) 31 21.5 
14 Kozak 2017
12 60 66.2±12.5 31 (51.7%) 11 18.3 
15 Kutlubaev 2013
29 96 68.0±10.5 46 (47.9%) 22 23.0 
16 Lees 2013
9 101 
74.0(median) 
IQR:64.0-85.0 
Not available 
for subgroup 
11 11.0 
17 Lees 2017
30 51 
74.0(median) 
range:67.0-84.0 
28 (54.9%) 8 16.0 
18 Lim 2017
6 576 
65.2(median) 
range:23.0-93.0 
208 (36.1%) 38 6.7 
19 McManus 2011
31 82 66.4±15.9 31 (37.8%) 23 28.0 
20 Mitasova 2012
14 129 71.2±11.5  57 (44.2%) 55 42.6 
21 Miu 2013
32 314 72.9±10.3 151 (48.1%) 86 27.4 
22 Mori 1987
33 41 68.2±10.9 15 (36.6%) 25 61.0 
23 Naidech 2013
10 114 63.0±13.8 52 (45.6%) 31 27.0 
24 Nydahl 2017
39 309 Not recorded  Not recorded 33 10.7 
25 Ojagbemi 2017
34 101 61.1±12.9 47 (46.5%) 
33 
 
33.3 
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26 Oldenbeuving 
201121 
527 
72.0(median) 
range:29.0-96.0 
239 (45.4%) 62 11.8 
27 Pasinska 2018
44 750 71.8±13.1 398 (53.1%) 203 27.1 
28 Reding 1993
35 44 66.0±13.0 25 (56.8%) 4 9.0 
29 Rosenthal 2018
45 150 Not recorded 
Not available 
for subgroup 
53 30.0 
30  Sheng 2006
36 156 79.2±6.7 73 (46.8%) 39 25.0 
31 Song 2018
46 54 73.7±6.7 25 (46.3%) 13 24.0 
32 Turco 2013
37 176 81.7±6.4 118 (67.0%) 58 33.0 
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Table 3.Risk of bias 
 
 Patient 
Selection 
Ascertainment  
stroke 
Ascertainment  
delirium 
Analysis 
1 Alvarez-Perez 2018
40     
2 Caeiro 2004
23      
3 Dahl 2010
24     
4 Dostović 2008
38     
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Colour coding: green for low risk of bias, yellow for uncertain risk and red for high risk 
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